During the past decade, Dallas VA Medical Center conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 33 clinical trials were completed, i.e. on average, 91.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 11 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dallas VA Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 25 trials, followed by "Dallas VA Medical Center" with 20 trials sponsored, "SWOG Cancer Research Network" with 17 trials sponsored, "North Texas Veterans Healthcare System" with 9 trials sponsored and "National Cancer Institute (NCI)" with 9 trials sponsored. Other sponsors include 75 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dallas VA Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "Boston Scientific Corporation" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator and "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include 105 different institutions and companies that were collaborators in the rest 96 trials.

According to Clinical.Site data, the most researched conditions in "Dallas VA Medical Center" are "Coronary Artery Disease" (13 trials), "HIV Infections" (9 trials), "Lung Cancer" (9 trials), "Lymphoma" (7 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "Dallas VA Medical Center" in a lesser frequency.

Most popular intervention types in "Dallas VA Medical Center" are "Drug" (101 trials), "Device" (27 trials), "Procedure" (22 trials), "Other" (18 trials) and "Biological" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "cisplatin" (7 trials), "etoposide" (7 trials), "radiation therapy" (7 trials) and "carboplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Dallas VA Medical Center" are 144 trials for "All" genders, 8 trials for "Male" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Dallas VA Medical Center". undefined are not yet recruiting, 10 are recruiting, 9 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 102 completed trials in Dallas VA Medical Center, undefined suspended trials, and 27 terminated clinical trials to date.

Out of the total trials that were conducted in Dallas VA Medical Center, 6 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 36 trials that are defined as “Not Applicable".